<h4>Introduction</h4>Diabetic gastroparesis increases the risk of aspiration, pneumonia, and sepsis, yet the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on these outcomes is uncertain because of their gastric-emptying effects.<h4>Methods</h4>We performed a retrospective cohort study using the TriNetX Global Research Network. The gene discussed is GLP1R; the disease is Sepsis.